Vogt, Johannes | Kepser, Lara-Jane - C 17

Bioactive lipid signaling in adult neurogenesis and metabolic modulation

Prof. Dr. Johannes Vogt
Prof. Dr. Johannes Vogt

Department of Molecular and Translational Neurosciences | Institute II of Anatomy

CMMC - PI - C 17

Department of Molecular and Translational Neurosciences | Institute II of Anatomy

Joseph-Stelzmann Str. 9

50931 Cologne

Dr. Lara-Jane Kepser
Dr. Lara-Jane Kepser

Department of Molecular and Translational Neurosciences | Institute II for Anatomy

CMMC - Co-PI - C 17

Department of Molecular and Translational Neurosciences | Institute II for Anatomy

Kerpener Str. 62

50937 Cologne

Introduction

We have shown that bioactive phospholipids such as lysophosphatidic acids (LPA) play important roles in synaptic neurotransmission and plasticity (1-5). LPA is a short-lived mediator with a half-time in the subminute range, but a potent signaling molecule acting via specific G-protein coupled receptors, LPA-R1-6. LPA-levels are tightly regulated by specific phosphatases (LPP1-3) suggesting that LPA synthesis and action are locally restricted. LPA is synthesized by the enzyme autotaxin (ATX) from the lipid precursor lysophosphatidyl choline (LPC). LPC is derived from the peripheral lipid metabolism and is actively transported into the CNS present at perisynaptic astrocytic processes In the cortex, ATX is expressed by astrocytes and is located at glutamatergic synapses where it fuels LPA levels by conversion of LPC into LPA (6, 7). However, in contrast to blood plasma, LPC is only present at very low concentrations in the CSF, indicating that LPC-levels are a limiting factor for LPA-synthesis in the CNS.  At glutamatergic synapses, LPA is a powerful modulator of presynaptic glutamate release by activation of presynaptic LPA2 receptors, which regulate glutamate release probabilities and hereby neuronal excitability. Our recent data show, that LPA regulates the excitation-inhibition (E/I) balance in cortical networks and controls cortical sensory information processing in mice and humans in a similar way(8, 9). 

While LPA effects are mediated by presynaptic LPA2-receptors (LPA2), plasticity-related gene-1 (PRG-1/LPPR4), a regulatory molecule located at the postsynaptic density of excitatory synapses, controls synaptic LPA-levels by transmembrane transport into intracellular compartments (3, 9). Hereby, PRG-1 regulates presynaptic LPA2 signaling and controls the functional set-point at the glutamatergic synapse. Alteration of this postsynaptic regulatory mechanism by PRG-1 results in higher local LPA levels, which lead to increased glutamatergic release probabilities, higher neuronal excitability and consequently to a shift in cortical network E/I-balance towards higher excitability (3, 9). 

Our previous data show that altered E/I-balance affected memory formation and led an endophyotype of psychiatric disorders in mice and humans(8). Moreover, since the LPA-precursor LPC is secreted by the liver and underlies metabolic alterations, our data show the changes in peripheral energy metabolism may rapidly affect brain lipid levels and thereby cortical excitability(10). In disease conditions however, synaptic lipid signaling is critically involved in stroke pathophysiology (11). Our recent data suggest that synaptic LPA synthesis in regions with high neuronal density like the hippocampus may provide a niche supporting adult neurogenesis. In fact, our data show that local LPA-synthesis in the hippocampal dentate gyrus plays a regulatory role in adult neurogenesis leading to improved survival and circuit integration of newborn neurons. 

Figure 1

Clinical Relevance

Regeneration in the adult brain is limited. However, adult neural stem cells (aNSC) retain self-renewal ability and are a potential source for neuroregeneration. Excitatory activation of newborn neurons was even suggested to reverse disease-related changes as shown in an animal model of frontotemporal dementia (Terreros-Roncal et al., 2019). However, even in large brain lesions i.e. following stroke, replacement of lost neurons by adult-born neurons is minimal. Insofar, there is still an urgent need to understand novel regulatory mechanisms of aNSC biology, which may lead to new options for postlesional regeneration. 

Approach

We use genetic modified animal models to specifically disrupt synaptic lipid signaling, in-vivo labeling of adult generated neurons, cell biological analyses of hippocampal stem cells and hippocampal cultures, electrophysiology and mRNA-Seq to unravel LPA signaling underlying successful neurogenesis, reduced cell death and circuit integration of adult born neurons. 

  1. J. Cheng et al., Precise Somatotopic Thalamocortical Axon Guidance Depends on LPA-Mediated PRG-2/Radixin Signaling. Neuron92, 126-142 (2016).
  2. X. Liu et al., PRG-1 Regulates Synaptic Plasticity via Intracellular PP2A/beta1-Integrin Signaling. Developmental cell38, 275-290 (2016).
  3. T. Trimbuch et al., Synaptic PRG-1 modulates excitatory transmission via lipid phosphate-mediated signaling. Cell138, 1222-1235 (2009).
  4. P. Unichenko et al., Plasticity-Related Gene 1 Affects Mouse Barrel Cortex Function via Strengthening of Glutamatergic Thalamocortical Transmission. Cerebral cortex26, 3260-3272 (2016).
  5. J. Vogt et al., Synaptic Phospholipid Signaling Modulates Axon Outgrowth via Glutamate-dependent Ca2+-mediated Molecular Pathways. Cerebral cortex27, 131-145 (2017).
  6. C. Thalman et al., Astrocytic ATX fuels synaptic phospholipid signaling involved in psychiatric disorders. Molecular psychiatry23, 1685-1686 (2018).
  7. C. Thalman et al., Synaptic phospholipids as a new target for cortical hyperexcitability and E/I balance in psychiatric disorders. Molecular psychiatry23, 1699-1710 (2018).
  8. O. Tuscher et al., Altered cortical synaptic lipid signaling leads to intermediate phenotypes of mental disorders. Molecular psychiatry,  (2024).
  9. J. Vogt et al., Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP. EMBO molecular medicine8, 25-38 (2016).
  10. H. Endle et al., AgRP neurons control feeding behaviour at cortical synapses via peripherally derived lysophospholipids. Nat Metab4, 683-692 (2022).
  11. L. Bitar et al., Inhibition of the enzyme autotaxin reduces cortical excitability and ameliorates the outcome in stroke. Science translational medicine14, eabk0135 (2022)

Lab Website

For more information about the research, please visit AG Prof Vogt.

2024 (up to June)
  • Tuscher O, Muthuraman M, Horstmann JP, Horta G, Radyushkin K, Baumgart J, Sigurdsson T, Endle H, Ji H, Kuhnhauser P, Gotz J, Kepser LJ, Lotze M, Grabe HJ, Volzke H, Leehr EJ, Meinert S, Opel N, Richers S, Stroh A, Daun S, Tittgemeyer M, Uphaus T, Steffen F, Zipp F, Gross J, Groppa S, Dannlowski U, Nitsch R, and Vogt J (2024). Altered cortical synaptic lipid signaling leads to intermediate phenotypes of mental disorders. Mol Psychiatry. doi:10.1038/s41380-024-02598-2.
2023
  • Barham M, Andermahr J, Majczynski H, Slawinska U, Vogt J, and Neiss WF (2023). Treadmill training of rats after sciatic nerve graft does not alter accuracy of muscle reinnervation. Frontiers in Neurology 13. doi:Artn 105082210.3389/Fneur.2022.1050822.
     
  • Knierim E, Vogt J, Kintscher M, Ponomarenko A, Baumgart J, Beed P, Korotkova T, Trimbuch T, Panzer A, Steinlein OK, Stephani U, Escayg A, Koko M, Liu Y, Lerche H, Schmitz D, Nitsch R, and Schuelke M (2023). Mutations in plasticity-related-gene-1 (PRG-1) protein contribute to hippocampal seizure susceptibility and modify epileptic phenotype. Cereb Cortex 33, 7454-7467. doi:10.1093/cercor/bhad051.
     
  • Nawshirwan S, Heucken N, Piekarek N, van Beers T, Fulgham-Scott N, Grandoch A, Neiss WF, Vogt J, and Barham M (2023). Morphological, ultrastructural, genetic characteristics and remarkably low prevalence of macroscopic Sarcocystis species isolated from sheep and goats in Kurdistan region, Iraq. Front Vet Sci 10, 1225796. doi:10.3389/fvets.2023.1225796.